DrugPatentWatch Database Preview

Enzalutamide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for enzalutamide and what is the scope of enzalutamide patent protection?

Enzalutamide is the generic ingredient in one branded drug marketed by Astellas and is included in one NDA. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for enzalutamide. One supplier is listed for this compound.

Summary for enzalutamide

US Patents:	3
Tradenames:	1
Applicants:	1
NDAs:	1
Drug Master File Entries:	9
Suppliers / Packagers:	1
Bulk Api Vendors:	81
Clinical Trials:	211
Patent Applications:	180
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for enzalutamide
DailyMed Link:	enzalutamide at DailyMed

Pharmacology for enzalutamide

Drug Class	Androgen Receptor Inhibitor
Mechanism of Action	Androgen Receptor Antagonists Cytochrome P450 3A4 Inducers Cytochrome P450 2C9 Inducers Cytochrome P450 2C19 Inducers

Synonyms for enzalutamide

4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N-me

4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N-methylbenzamide

4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-imidazolidin-1-yl]-2-fluoro-N-methyl-benzamide

4-{3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl}-2-fluoro-N-methylbenzamide

4-{3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl}-2-fluoro-N-methylbenzamide

915087-33-1

93T0T9GKNU

A25302

AB0008149

AB01565849_02

ABP000459

AC-26924

ACN-026804

AK-72825

AKOS015851022

AMX10212

AN-16279

ANW-54164

AOB87731

API0007596

AS-17047

ASP-9785

AX8165432

BC660065

BCP9000901

BCPP000169

BDBM50425732

Benzamide, 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-N-methyl-

Benzamide,4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methyl-

BR-72825

BRD-K56851771-001-01-9

C21H16F4N4O2S

CHEBI:68534

CHEMBL1082407

CJ-18592

CS-0317

CTK8B6725

D0M1YR

D0QK5X

D10218

DB08899

Enzalutamide (AR inhibitor)

Enzalutamide (JAN/USAN)

Enzalutamide (MDV3100)

Enzalutamide [USAN:INN]

EX-A046

FT-0670957

GTPL6812

HE069450

HMS3654L07

HY-70002

J-519668

KB-53497

KS-0000079W

MDV 3100

MDV-3100

MDV-3100, 915087-33-1

MDV3100

MDV3100 (Enzalutamide)

MDV3100 Enzalutamide

MDV3100, 95%

MDV3100, AldrichCPR

MDV3100/MDV-3100

MDV3101

MFCD14155804

MLS006010067

MolPort-009-679-470

n-methyl-4-[3-(4-cyano-3-trifluoromethylphenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl]-2-fluo

NC-54

NCGC00263120-01

PubChem19320

QCR-130

RL05765

S-3847

s1250

SC-69109

SCHEMBL189749

SMR004701227

SR-01000941580

SR-01000941580-1

ST24028748

TC-142909

Tube704

UNII-93T0T9GKNU

W9480

WXCXUHSOUPDCQV-UHFFFAOYSA-N

XTANDI

Xtandi (TN)

ZINC34806477

US Patents and Regulatory Information for enzalutamide

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Astellas	XTANDI	enzalutamide	CAPSULE;ORAL	203415-001	Aug 31, 2012		RX	Yes	Yes
Astellas	XTANDI	enzalutamide	CAPSULE;ORAL	203415-001	Aug 31, 2012		RX	Yes	Yes
Astellas	XTANDI	enzalutamide	CAPSULE;ORAL	203415-001	Aug 31, 2012		RX	Yes	Yes			Y	Y
Astellas	XTANDI	enzalutamide	CAPSULE;ORAL	203415-001	Aug 31, 2012		RX	Yes	Yes

International Patents for enzalutamide

Country	Document Number	Estimated Expiration
South Korea	20080014039
Denmark	1893196
Australia	2007245022
European Patent Office	2444085
Hong Kong	1169321
South Korea	20150086567

Supplementary Protection Certificates for enzalutamide

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
90060-0	Sweden		PRODUCT NAME: ENZALUTAMID OCH FARMACEUTISKT ACCEPTABLA SALTER DAERAV; REG. NO/DATE: EU/1/13/846 20130621
2013000155	Germany		PRODUCT NAME: ENZALUTAMID ODER EIN PHARMAZEUTISCH VERTRAEGLICHES SALZ HIERVON; REGISTRATION NO/DATE: EU/1/13/846 20130621
13/061	Ireland		PRODUCT NAME: ENZALUTAMIDE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTRATION NO/DATE: EU/1/13/846 20130625
338	Luxembourg		PRODUCT NAME: ENZALUTAMIDE ET SES SELS PHARMACEUTIQUEMENT ACCEPTABLES (XTANDI); FIRST REGISTRATION DATE: 20130625
C0071	France		PRODUCT NAME: ENZALUTAMIDE OU SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE: EU/1/13/846 20130625
2013 00065	Denmark		PRODUCT NAME: ENZALUTAMID ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/13/846 20130625